about
Consistency in seroma contouring for partial breast radiotherapy: impact of guidelinesStereotactic Radiosurgery for Metastases in Eloquent Central Brain Locations.A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion.Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases.Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-Arm, Phase 2 Study.4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.Quantification of masticatory muscle atrophy after high-dose radiotherapy.Integration of on-line imaging, plan adaptation and radiation delivery: proof of concept using digital tomosynthesis.Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast.A Cross-Sectional Cohort Study of Cerebrovascular Disease and Late Effects After Radiation Therapy for Craniopharyngioma.Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis.Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy.High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.An anthropomorphic phantom study of visualisation of surgical clips for partial breast irradiation (PBI) setup verification.Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.Signed family physician reminder letters to women overdue for screening mammography: A randomized clinical trial.Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy.EGFR mutation status on brain metastases from non-small cell lung cancer.Assessment of a model-based deformable image registration approach for radiation therapy planning.Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC Cancer Agency.A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers.Accuracy and sensitivity of finite element model-based deformable registration of the prostate.Validation of supervised automated algorithm for fast quantitative evaluation of organ motion on magnetic resonance imaging.Direct aperture optimization for online adaptive radiation therapy.Intra-prostatic fiducial markers and concurrent androgen deprivation.Inverse Relationship Between Biochemical Outcome and Acute Toxicity After Image-Guided Radiotherapy for Prostate CancerA phase II study of localized prostate cancer treated to 75.6Gy with 3D conformal radiotherapyLong-Term Outcomes and Complications in Patients With Craniopharyngioma: The British Columbia Cancer Agency ExperienceAnalysis of treatment parameters for conformal shaped field stereotactic irradiation: comparison with non-coplanar arcsRole of fractionated external beam radiotherapy in hemangioblastoma of the central nervous systemThree-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapyA case-match study comparing unilateral with synchronous bilateral breast cancer outcomesIntervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapyThe impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort studyOutcomes of node-negative breast cancer 5 centimeters and larger treated with and without postmastectomy radiotherapyLong-term mortality from cardiac causes after adjuvant hypofractionated vs. conventional radiotherapy for localized left-sided breast cancerClose Margins Less Than 2 mm Are Not Associated With Higher Risks of 10-Year Local Recurrence and Breast Cancer Mortality Compared With Negative Margins in Women Treated With Breast-Conserving Therapy
P50
Q28263037-18FB4685-E17D-40EF-BD44-CA9916E62701Q30969391-B3986759-6683-419A-BA4A-073D8F81DB18Q33443754-1DC802A6-EF72-4960-8AC2-B0E1D424714AQ34430417-2F91A97F-B13B-4078-8B9C-E7DD8F70D3AAQ38398359-30BBD850-D6E9-4CAC-BB31-9C83ACD2A698Q39484286-6C9F4378-5D75-4FDF-9D6A-75D586892480Q39653246-D1AEFC0E-602C-46C8-9ECD-5EEA11066106Q39886836-41F3CF7F-E5EB-40B0-8200-D1ABAC6E65EDQ40122873-5676D2FE-EA3C-4344-BBE9-14A4153CE86FQ40847579-EE83543B-7824-44D1-B381-9B2EB46E75A4Q40983815-09459330-189A-4441-B853-C07AB08B9F20Q41126968-6C0D803A-C3EB-402F-8928-518C3637B2F2Q44084080-ECADCEE4-B4C1-4102-8BF8-A26F6013649CQ45949517-4D9D913B-BCA4-4B9A-89CB-2C0B7AD2CC6CQ46021366-42D4EE9B-A7B9-4908-9E1D-B771593B33B3Q46507042-E21128CB-E350-48FF-AFC7-5BC0AE659AF0Q47768696-555F708E-B37D-4ED6-9D94-A9576B1C7B3CQ48125418-BEB6BED0-13FB-4DE4-BFF0-DD11F98EEE02Q48269710-E3241071-1073-4B08-B0AE-ECFAF9ADB73FQ48511529-63705E28-0961-4FAF-B06D-3AE92B11236EQ48776799-F98210D1-0DB5-485B-A992-EDF33202EA50Q48910626-8E95205B-BE20-4B4D-9D6C-D7A3AF83B5A4Q49149162-04D9626B-D736-4A2C-8920-642162B7166EQ51108953-00B66728-B44C-428E-BFF4-B9985EA370FEQ51867441-D628955C-C238-4AAD-9A67-23613AFB9E64Q51896462-64E97A32-DFB0-41B5-9A08-CC79C4AEDE01Q51913022-5E5CB089-27CC-4D4E-A78A-EB3C6E4779CFQ53571013-1F42697C-5F24-4862-AF58-6EBD44128691Q59007680-F49C9FEC-83B5-4320-8914-F60669468E45Q59008946-860982A9-0491-43A2-B266-70B29D2272C2Q60486997-E55F4D0D-FD5C-44A3-9F7C-992BBCCA28F4Q77425556-2BBCD479-ABD9-499D-84DA-836034DECC32Q81296923-DEFB1A9D-1500-45DC-9D38-5FA2864CC09AQ82032554-52C2A3D2-CC0C-4BC0-9541-3BA7557067BBQ82621410-6E5B5ACB-7E75-42E7-BB52-9E041FFC9228Q82653332-8DDCD20F-1C97-4F18-AD62-2A6B4CD50FABQ83816327-B6056BCA-2C7C-4580-934B-E66714DCED70Q84582365-9E15DC03-BA65-45EF-A5B1-A7CA9B0A81D1Q85323587-38992792-16B7-4C07-B453-58A9ACD6CAB7Q88425215-FD50C315-EA14-45C3-9E99-471C75913B39
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alan M Nichol
@nl
Alan M Nichol
@sl
Alan M. Nichol
@en
Alan M. Nichol
@es
type
label
Alan M Nichol
@nl
Alan M Nichol
@sl
Alan M. Nichol
@en
Alan M. Nichol
@es
prefLabel
Alan M Nichol
@nl
Alan M Nichol
@sl
Alan M. Nichol
@en
Alan M. Nichol
@es
P106
P1153
8693430700
P21
P31
P496
0000-0002-4146-881X